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Background: Stroke remains to be a major burden of disease, often causing death or physical impairment or
disability. This paper estimates the economic burden of stroke in a large county of 1.5 million inhabitants in
western Sweden.
Methods: The economic burden of stroke was estimated from a societal perspective with an incidence approach.
Data were collected from clinical registries and 3,074 patients were included. In the cost calculations, both direct
and indirect costs were estimated and were based on costs for 12 months after a first-ever stroke.
Results: The total excess costs in the first 12 months after the first-ever stroke for a population of 1.5 million was
629 million SEK (€69 million). Men consumed more acute care in hospitals, whereas women consumed more
rehabilitation and long-term care provided by the municipalities. Younger patients brought a significantly higher
burden on society compared with older patients due to the loss of productivity and the increased use of resources
in health care.
Conclusions: The results of this cost-of-illness study were based on an improved calculation process in a number
of fields and are consistent with previous studies. In essence, 50% of costs for stroke care fall on acute care hospital,
40% on rehabilitation and long-time care and informal care and productivity loss explains 10% of total cost for the
stroke disease. The result of this study can be used for further development of the methods for economic analyses
as well as for analysis of improvements and investments in health care.
Keywords: Burden, Cost of illness, Health economics, Incidence cost, Stroke, SwedenBackground
Stroke continues to be a major burden of disease [1,2]
even when the risk of premature death has been reduced
[3]. Several assessments of the direct and indirect costs
have been published [4-9]. In Sweden, the compre-
hensive statistics from providers on the utilization of in-
hospital, municipal and long-time care make it possible
to evaluate the costs from a wide societal perspective in
detail [10]. Sweden, like many Organisation for Eco-
nomic Co-operation and Development (OECD) coun-
tries, faces a problem of an increasing fraction of elderly
persons, who will in the long run lead to a heavy burden
on society and the working population [11]. Thus, the fi-
nancial burden of diseases such as stroke is important.* Correspondence: josefine.persson@vgregion.se
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reproduction in any medium, provided the orThe Swedish health care model is based on the goal to
provide good health and high-quality care on equal
terms for the entire population. Residents in Sweden
have equal rights of access to care based on the medical
needs and in accordance with evidence-based medicine
and proven experience. Those who are in greater need
should take precedence, regardless of their ability to pay,
place of residence, social status or other factors that are
medically irrelevant. Health care should also be cost-
effective, and the resources within the health care system
should be used so that maximum gain is reached to
meet the needs of the population. The Swedish health
care system is highly decentralised with three levels, the
state, the counties and the municipalities. The state sets
the regulations but does not provide care. The counties
provide all health care including hospital, acute care and
primary care whereas the municipalities provide rehabili-
tation, long-time care and home aid (Figure 1). All unitsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Providers in Swedish health care system. Source: Integrated Care in Europe. Description and comparison of integrated care in six EU
countries. Elsevier Gezondheidszorg, 2003.
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taxes.
A health economic analysis of a disease implies that
there is information available regarding the use of
resources at different levels in the chain of health care
and society. By using the social security number, Sweden
has a unique ability to follow one patient throughout the
whole chain of health care within the Swedish adminis-
trative registries. In this paper, relevant data were
selected to provide a complete picture of the burden of
stroke in Västra Götaland, a county in western Sweden
including health care consumption, municipal care, po-
tential productivity loss and informal care by relatives.
The aim of this exploratory study was to present the
societal costs of first-ever stroke during 2008 in Västra
Götaland, a large county in western Sweden, which has
1.5 million inhabitants. The study identified, quantified
and valued all costs for health care, rehabilitation, long-
term care and home aid and potential productivity loss.
Also, all costs for patients and families during the first
12 months after the first-ever stroke as well as lifetime
costs, were estimated. This study analysed the costs aris-




Stroke is a clinical syndrome with several different
pathologies [12]. In this study we defined stroke as Inter-
national Classification of Disease, 10th revision (ICD-10)
codes I61 (intracerebral haemorrhage), I63 (cerebral in-
farction) and I64 (stroke, not specified as haemorrhage
or infarction) [13]. According to local data of health careconsumption from the county council, 4,242 stroke
events were reported in 2008, of which 3,074 cases
(72%) were first-ever stroke. This proportion is in ac-
cordance with a previous study conducted in Sweden
[5]. The sex distribution in the whole group was equal
(Table 1). However, in the age group below 55, the pro-
portion of men was 67%, whereas in the age group above
85 the proportion of women was 66%. This could partly
be explained by women living longer than men [14].
Comorbidity such as atrial fibrillation and hypertension
indicates risk factors for first-ever stroke (Table 1).
Health-related quality of life decreased with age, i.e.
patients over 85 had the lowest self-reported health-
related quality of life. Women had lower self-reported
health-related quality of life and impaired mobility com-
pared with men (Table 2).
Data source
To identify, quantify and value events and contacts at-
tributable to stroke, identifying the chain of healthcare is
important. It is then possible to estimate all costs occur-
ring in each step of the chain (Figure 2). Retrospective
data were extracted from the local administrative regis-
ter and a national clinical register, The Stroke Register,
to calculate resources attributable to stroke. The clinical
register contains information on stroke admissions in
Sweden [15], comorbidity, health-related quality of life,
medication, admissions to municipal care and depend-
ence on relatives. Collection of data into the national
clinical registries is based on the law SFS 2008:355. Local
data of health care consumption were extracted from
the county council of Västra Götaland [10], containing
health care consumption for inpatients care as well as
Table 1 Demographic and clinical variables for patients












Atrial fibrillation 27.3 (5*)
Diabetes mellitus 18.9 (5*)
Hypertension 55.8 (19*)






Total number of patients n = 3,074.
Data source: Local administrative register and The Stroke Register.
*Reference value for the age-matched Swedish population, according to The
Swedish National Institute of Public Health.
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of admission and discharges, primary diagnosis (ICD-10)
and type of ward, and data for outpatient care contained
date visit, primary diagnosis (ICD-10), type of medical
personnel and type of clinic/facility. To calculate the ex-
cess cost for stroke, health care consumption data were
extracted one year before and one year after the stroke
onset for each individual. Collection and utilisation of
data for assessment is based on the law SFS 2008:355Table 2 Age-related differences in health-related quality
of life and mobility three month after first-ever stroke
onset for patients in western Sweden during 2008
Age, sex EQ-5D Impaired mobility,%
<54 years 68.3 (75.0*) 13.5
55-64 years 70.7 (73.0*) 10.9
65-74 years 68.4 (72.4*) 16.9
75-84 years 64.9 (68.8*) 31.9
>85 years 58.5 (64.6*) 48.5
Female 64.1 (73.5*) 33.0
Male 70.3 (73.8*) 19.7
Total number of patients n = 3,074.
Data source: The Stroke register.
*Reference value for the Swedish population. Source: Ferraz-Nunes J: Hälsa, ett
värde utan pris (Health, a value without price), Holmberg & Weibull (red). Det
nya samhället (The new society), SOM. Sweden: Gothenburg University;
2000:93–110.and the Health Act HSL 36 }. To complement and verify
the local administrative data, macro data were extracted
from The Stroke Register. We did not use individual
data from this source. We did not collect primary data
and use individual data, and approval from the ethics
committee was not relevant.
Direct costs in health care
Data were collected, based in an incidence method, to
estimate disease cost for first-ever stroke patients for a
single year. Inpatient care costs were calculated accord-
ing to age intervals, sex and diagnosis. The cost of emer-
gency and inpatient care consists of the costs of all care
episodes that began in the year 2008 for a period of
12 months after the stroke. Most patients had only one
treatment episode, but some patients had more episodes
during the 12-month period. Each episode includes
basic, intensive care, nursing, diagnosis, blood transfu-
sion and rehabilitation costs (Table 3). Costs for out-
patient care varied to a larger extent than costs for
inpatient care due to the differences between patients in
age and disabilities caused by stroke. Cost-driving con-
tacts after discharge were visits with doctors and nurses,
rehabilitation with physiotherapists, occupational thera-
pists, speech therapists and counsellors (Table 3). Data
collection was based on number of visits over the 12-
month period. Costs per contact and per hospitalisation
day were based on prices in the county and includes
overhead, equipment and personnel costs. The average
cost per patient in each age group was calculated.
Municipal cost
As this is a study of excess costs, municipal costs were
calculated based on the change in the use of rehabilita-
tion as well as long-term care and home aid before and
after the stroke, respectively based on information from
The Stroke Register. Municipal excess costs were small
for individuals who had already used a great deal of care
before the stroke. Costs for patients who died during the
first three months after the stroke were limited. The
average per diem cost was based on information from
municipal professional workers.
Informal care volume
Estimates of the volume of hours spent on informal care
were based on the information in The Stroke Register,
which was verified by interviews with caregivers and
employees within the municipalities. According to the
register, 2,076 patients reported that they were entirely
or partly dependent on their informal caregiver. It was
estimated that those who were entirely dependent on
their informal caregiver received four hours each day
and those who were partly dependent on their informal
caregiver received four hours each week. For patients
Figure 2 Chain of health care for stroke survivors in Sweden.
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cause data from The Stroke Register on this age group
indicated consumption of municipal care to a larger ex-
tent before the stroke.
Informal care costs
The opportunity cost method was used to calculate the
socioeconomic value of informal care, meaning the value
of the informal caregiver’s best alternative use for this
time, which may be the loss of income including social
security contributions and/or loss of leisure time.
According to previous studies, informal care is mainly
given by the patient’s partner [16-18]. Patients in the ageTable 3 Main unit cost per resource use items in hospital
care, municipal rehabilitation and aid service, average
income and informal care for patients with first-ever
stroke in western Sweden during 2008
Cost item Unit SEK (€)
Pre-hospital
Ambulance transportation 2000 (220)
Own transportation 1000 (110)
Inpatient care Per diem 5400 (600)
Outpatient care
Medical specialist Per visit 4000 (440)
General practitioner Per visit 2000 (220)
Speech therapist Per treatment 800–6100 (90–700)
Other Per visit 1800 (200)
Municipal care
Municipal home care Per diem 480 (50)
Municipal assistant living Per diem 1600 (180)
Average income Per month 35000 (3900)
Informal care
Working age Per hour 200 (20)
Pension age Per hour 70 (8)
Prices of year 2008 in SEK and (€).
Based on converting currency rate 1 June 2012 (1 SEK= €0,11).
Data source: see methods.group below 65 were estimated to have partners in
working age, and were therefore estimated to have a loss
of income of 200 SEK per hour based on the average in-
come in western Sweden during 2008 calculated by from
Statistics Sweden [19]. This includes an estimation of
25% on sick leave or disability pension. Patients above
65 were estimated to have partners not in working age
and therefore to have a loss of leisure time of 70 SEK
per hour, which is 35% [20] of the production loss value
(Table 3).
Cost for loss of productivity
Estimation of cost for loss of productivity was based on
sick leave and early retirement due to the ICD-10 codes
I61, I63 and I64 in the year 2008. This information was
obtained from the social insurance authority, which reg-
isters all absence to work in Sweden. Another two weeks
were added to the time the sick leave because this period
is not included in the initial phase of sick leave covered
by the insurance. The period was calculated in working
days and then multiplied by average day-income includ-
ing social security contributions based on the average
monthly market income in the county [19] (Table 3).
Total potential productivity loss was recalculated with a
factor that takes into account absence from work due
other causes such as unemployment and other sick-
nesses. By this, the employment status of the patients
before and after stroke was taken in consideration and a
measure of lost social potential production was calcu-
lated. The period was calculated in working days and
then multiplied by average income including social se-
curity contributions, which is a measure of output from
a market perspective. The potential productivity loss was
estimated based on the human capital approach.
Lifetime costs
Estimation of lifetime costs was based on estimated ex-
cess total cost in the first three years after first-ever
stroke. The calculation of the first year corresponds to
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ing the exact real consumption of health care services,
community care and production loss. In the second year,
costs were estimated based on information about the
discharge of patients. This information includes mortal-
ity, survival rates, degree of handicap, change in the
need of community service, health care and long sick
leave. Future development of costs after three years were
adjusted based on data from clinical registries and other
studies [5,21]. Future costs were discounted to present
value using a discount rate of 3%. The structure of costs
is substantially different in the first year after stroke
compared with future costs. The weight of community
costs increased after the first year.
Results
Excess total costs
This study estimates the total excess care costs in the
first 12 months after first-ever stroke to be 629 million
SEK (€69 million) per year for a population of 1.5 mil-
lion in the Västra Götaland county, western Sweden
(Table 4). The excess cost means that the consumption
of non-stroke-related health care is ignored. Medical
expenses relating to resources used in inpatient and out-
patient care were estimated to be 49% of the total costs.
Municipal care costs were estimated to be 34% of theTable 4 Excess total costs for all patients, excess cost per pat




Inpatient care costs 280000
Outpatient care costs 22000
Municipal care costs 230000
Informal care costs total 39000
Productivity loss total 58000
Total costs 629000
Cost per patient
Average all patients 193
Patients under 55 years 280
Patients between 65–74 years 136
ICD-10 code I61 202
ICD-10 code I63 182
ICD-10 code I64 161
Lifetime costs
All patients 768
Patients under 55 years 2447
Patients over 85 years 423
Total number of patients n = 3,074. Prices of year 2008 in thousand SEK and (€).
Based on converting currency rate 1 June 2012 (1 SEK = €0,11).total costs. Patient’s loss of productivity is equal to the
value of lost production in society due to absence from
work and was estimated to be 9% of the total costs. The
socioeconomic value of the informal care costs for the
first year after the stroke was estimated to be 6% of total
costs.Excess cost per individual
The average excess cost per individual in the first year
after a first-ever stroke was calculated to be 193,000 SEK
(€21,200) (Table 4). However, this excess cost varied
greatly between individuals depending on age, sex, and
severity of the stroke. The average cost per individual
below 55 was more than twice as high as the cost for
individuals between 65 and 74. Of total costs, approxi-
mately 50% were related to health care and approxi-
mately 40% were related to municipal care. However,
this ratio differs significantly between age groups. For
individuals below 65, the proportion of health care costs
was greater whereas for the older individuals the propor-
tion of municipal care was greater. There were some dif-
ferences when the costs per individual were grouped in
the ICD-10 codes because a stroke caused by a cerebral
haemorrhage (I61) incurs the largest cost per individual.
Age-related differences in costs were similar among menient and lifetime costs for patients with first-ever stroke

















Figure 3 Cost per patient during three years after first-ever
stroke in western Sweden during 2008. Year 2008 prices in
thousand EURO.
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health care and women more municipal care (Table 5).
Excess costs the first three years
Costs after the first year after a first-ever stroke were sig-
nificant but had another structure compared with the
first year. During the first year, health care cost
accounted for the largest share of the cost whereas the
proportion of municipal service costs exceeded health
care costs after the first year (Figure 3). Lifetime costs
are extended through the remaining years of life and
were estimated to be 768,000 SEK (€84,500) in present
value (3% discount) per individual. However, the lifetime
cost per individual varied greatly depending on age. For
patients below 55, lifetime costs were almost six times
higher than for patients above 84. This variation was
mainly due to productivity loss for the working popula-
tion and in addition the health care and municipal care
for rehabilitation and aid that is needed for several years.
Generalizability and comparability
Costs for life time care are based on statistics for stroke
and demography. Changing case-mix may have an influ-
ence on the assumptions. As indicated from our results,
rising ages for patients with first stroke ever will lead to
decreasing overall societal costs. Also, as a previous study
[22] indicates, the incidence of stroke increases among the
younger population, especially among younger women.
These are probable scenarios and might affect the burden
of stroke in a different way than this study indicates.
Discussion
Methodological considerations
The estimated excess cost in this study gives a value of
the societal burden that could be saved if one stroke-
incidence could be avoided. One of the main strengths
of this study is the detailed information covering everyTable 5 Differences in excess costs per patient with first-
ever stroke in western Sweden during 2008 for females
and males
Cost item Female Male
SEK € SEK €
Inpatient care costs 88 (9.6) 95 (10.5)
Outpatient care costs 6 (0.7) 5 (0.5)
Total healthcare cost 94 (10.3) 103 (11)
Municipal care costs 78 (8.5) 72 (8)
Total direct costs 172 (19) 175 (19)
Productivity loss total 17 (2) 21 (2.3)
Total costs 189 (21) 196 (21.5)
Total number of patients n = 3,074. Prices of year 2008 in thousand SEK and
(€).
Based on converting currency rate 1 June 2012 (1 SEK= €0,11).part throughout the whole chain of health care in
addition to societal costs. This study gives indication of
the costs in the year 2008; however, there may be varia-
tions due to improvements the in health of the popula-
tion as an effect of new treatments as well as
preventions. By this, the result in this study can be used
as a basis to evaluate new improvements. Also, this
study could be used to initiate a discussion of cost and
priorities. However, the calculations have some limita-
tions. There is a lack of data at the individual level in
municipal care because only the county health care reg-
isters data on individual level. Municipal care is for legal
reasons not registered for single individuals, which
makes it impossible to perform a regression analysis ex-
ploring causality. However, the calculation of average
cost is not affected by this. Other published studies in
the field had the same problem [23]. Also, there are
some uncertainties in calculating the informal care due
lack of systematic evidence in the area, which may have
a significant influence in health economic analyses [11].
Thus, systematic data on informal care is an essential
area for further research.
Analysis of result
This study shows that the expenses for specialist health
care in the first year causes most of the excess costs of
stroke, but this cost varies between age groups. For indi-
viduals older than 75, most of the excess costs are within
the municipal care, e.g. rehabilitation and long-time
care. Within the health care, inpatient care costs domi-
nated. The study also shows that the excess costs vary
across age group, sex and diagnosis. Excess cost in the
younger age group is significantly higher than in the
older group due to more resources used in health and
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sumed more resources within health care and had a
higher level of productivity loss. Individuals who suffered
a cerebral haemorrhage (I61) consumed more resources
than other patients in all cost categories. Even though
this kind of stroke affects only few individuals, the indi-
viduals who are affected are younger and require most
resources, both within health care and municipal care.
The estimated opportunity cost for informal care is
an understatement due to lack of systematic data. How-
ever, this gives an indication of the family’s burden in
monetary terms.
Comparison with other studies
When comparing the result of this study with other
studies on the topic, differences in calculation methods
have to be considered. However, compared with previous
studies in Sweden, our study showed similar results to
other studies on an aggregate level. The most recent
study [5] in Sweden shows that the lifetime-cost per
individual was 725,000 SEK (€80,000) converted to
2008 year prices and with a discount rate of 3%. This
figure represents an average for Sweden. The life-time
cost in this study is calculated to be 768,000 SEK
(€84,500).
Comparisons with studies in other countries add even
more uncertainties due to different health care systems.
A European study by Porsdal and Boysen [7] showed dif-
ferences in the use of specific recourses within the
health care chain. For example in Denmark and Finland,
a large amount of rehabilitation resources are used. In
our study, we only estimated the rehabilitation use to
10% compared with the 23% in Porsdal’s study [7]. In
this study, the length of stay was about 12 days, whereas
the corresponding figure in Porsdal’s study was 33 days
[7]. This is an example of the different choices of re-
source allocation within the health care chain, which
have an effect on the overall costs.
Conclusions
The results of this cost of illness study are consistent with
previous studies, although we have the cost calculation
process in a number of fields. In essence, 50% of costs for
stroke care fall on acute care hospital, 40% on rehabilita-
tion and long-term care, informal care and productivity
loss explain 10% of total cost for the stroke disease. The
results of this study can be used as further development as
well as for improvements and investments in health care
as well as for development of econometric methods.
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